Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 December 2020 | Story Rulanzen Martin | Photo Supplied
The children who took part in the 2020 music programme received a certificate for completing the project.

The yearly Heidedal music outreach progamme presented by the Odeion School of Music (OSM) and the Reach our Community Foundation (ROC) is growing from strength to strength each year. Amid the uncertainties of 2020 three students from the OSM persevered and vowed to continue with the teaching progamme to bring music by the community for the community. 

This annual outreach programme was founded by the Music department at the OSM in 2015 and forms part of the BMus, BA (Music) and Diploma in Music qualification which integrates Music education modules with service learning.

This year’s progamme was established as an alternative to the Marimba Project which has been running for five years. “The aim is to continue with the programme in years to come, equipping and empowering the students to continue with instrumental training,” said Nadia Smith, a BAMus honours student and programme leader. 

Students take charge of 2020 programme 

Nadia Smith, together with third-year BMus students Liana Bester, and Chrismari Grobler, who all voluntarily took part in the progamme for six weeks, presented music lessons to 11 children in Heidedal. “Apart from the music knowledge these children gained they learned about teamwork and collaboration. They gained confidence and self-assurance, and reaped the fruit of their hard work,” said Smith.  

For Smith the six weeks of learning was a wonderful, joyous experience. “As a student music teacher, I am privileged to realise early in my career that to teach music is to teach life. Seeing the children smiling and performing enthusiastically I realised that everyone deserves to be educated in, about, and through music.”

Community concert also to engage and educate 

The teaching culminated in a much-anticipated community concert which took place on Saturday 14 November 2020. The community concert is presented as an ‘informance’, a collaboration between informing and performance. 
“It enables us to engage with the audience by inviting them to sing and move. We also demonstrated to them the process, development and outcomes of the programme,” said Smith. 

“In only 12 lessons the Heidedal students were exposed to different music styles including classical music, jazz and African music, and learned to read and write music notation, and to play the recorder,” said Smith. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept